| Product Code: ETC10587631 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Anthra Vaccine Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Anthra Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Anthra Vaccine Market - Industry Life Cycle |
3.4 Israel Anthra Vaccine Market - Porter's Five Forces |
3.5 Israel Anthra Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Anthra Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Anthra Vaccine Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Anthra Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of anthrax vaccination in Israel |
4.2.2 Government initiatives to prevent anthrax outbreaks |
4.2.3 Growing investments in research and development for anthrax vaccines |
4.3 Market Restraints |
4.3.1 Limited availability of anthrax vaccines in Israel |
4.3.2 Stringent regulatory requirements for vaccine approval |
4.3.3 High production costs leading to expensive vaccines |
5 Israel Anthra Vaccine Market Trends |
6 Israel Anthra Vaccine Market, By Types |
6.1 Israel Anthra Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Anthra Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Anthra Vaccine Market Revenues & Volume, By Live Attenuated, 2021 - 2031F |
6.1.4 Israel Anthra Vaccine Market Revenues & Volume, By Inactivated Vaccines, 2021 - 2031F |
6.1.5 Israel Anthra Vaccine Market Revenues & Volume, By Recombinant Vaccines, 2021 - 2031F |
6.1.6 Israel Anthra Vaccine Market Revenues & Volume, By Protein-Based Vaccines, 2021 - 2031F |
6.2 Israel Anthra Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Anthra Vaccine Market Revenues & Volume, By Human Immunization, 2021 - 2031F |
6.2.3 Israel Anthra Vaccine Market Revenues & Volume, By Veterinary Use, 2021 - 2031F |
6.2.4 Israel Anthra Vaccine Market Revenues & Volume, By Biodefense Programs, 2021 - 2031F |
6.2.5 Israel Anthra Vaccine Market Revenues & Volume, By Military Use, 2021 - 2031F |
6.3 Israel Anthra Vaccine Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Anthra Vaccine Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Anthra Vaccine Market Revenues & Volume, By Veterinary Clinics, 2021 - 2031F |
6.3.4 Israel Anthra Vaccine Market Revenues & Volume, By Government Agencies, 2021 - 2031F |
6.3.5 Israel Anthra Vaccine Market Revenues & Volume, By Research Centers, 2021 - 2031F |
7 Israel Anthra Vaccine Market Import-Export Trade Statistics |
7.1 Israel Anthra Vaccine Market Export to Major Countries |
7.2 Israel Anthra Vaccine Market Imports from Major Countries |
8 Israel Anthra Vaccine Market Key Performance Indicators |
8.1 Number of reported anthrax cases in Israel |
8.2 Percentage of population vaccinated against anthrax |
8.3 Research and development expenditure for anthrax vaccines in Israel |
9 Israel Anthra Vaccine Market - Opportunity Assessment |
9.1 Israel Anthra Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Anthra Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Anthra Vaccine Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Anthra Vaccine Market - Competitive Landscape |
10.1 Israel Anthra Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Israel Anthra Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here